Vanda Pharmaceuticals buy StockNews.com
Start price
29.07.23
/
50%
€5.25
Target price
29.07.24
-
Performance (%)
-3.81%
Price
14:26
€5.05
Summary
This prediction is currently active. With a performance of -3.81%, the BUY prediction by StockNews_com is trending in the wrong direction. This prediction currently runs until 29.07.24. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Vanda Pharmaceuticals | 9.574% | 9.574% |
iShares Core DAX® | -0.051% | 4.829% |
iShares Nasdaq 100 | 1.659% | 2.417% |
iShares Nikkei 225® | 0.658% | -2.173% |
iShares S&P 500 | 0.964% | 2.547% |
Comments by StockNews_com for this prediction
In the thread Vanda Pharmaceuticals diskutieren
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for VNDA provided by MarketBeat